MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Institutional Shareholders

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.31B in MLTX holdings during the latest filing period.

Bvf Inc/Il is currently the largest disclosed institutional shareholder of MLTX tracked by InsiderSet, reporting ownership valued at approximately $311.54M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $263.54M, representing an estimated loss of -15.41% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed MLTX value among the investors covered in this analysis. Major shareholders include Bvf Inc/Il, Deep Track Capital, Lp, D. E. Shaw & Co., Inc., and several other long-term asset managers with concentrated positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX).

This page ranks the largest institutional MLTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

169

Total Reported Value

$1.31B

Largest Holder

Bvf Inc/Il

Largest Position

$311.54M

Insider Transactions (90d)

14

Latest Filing Quarter

Q2 2026

New Institutional Positions

95

Funds Exiting Positions

0

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Bvf Inc/Il7.97%16,001,284$311,544,999$263,541,147-$48,003,852-15.41%
Deep Track Capital, Lp2.01%6,999,025$136,271,017$115,273,942-$20,997,075-15.41%
D. E. Shaw & Co., Inc.0.04%3,365,507$65,526,421$55,429,900-$10,096,521-15.41%
Janus Henderson Group Plc0.03%3,451,628$64,303,830$56,848,313-$7,455,517-11.59%
Cormorant Asset Management, Lp3.20%3,205,433$62,409,781$52,793,482-$9,616,299-15.41%
Logos Global Management Lp2.24%2,675,000$52,082,250$44,057,250-$8,025,000-15.41%
Weiss Asset Management Lp0.56%2,581,813$50,267,899$42,522,460-$7,745,439-15.41%
Citadel Advisors Llc0.02%1,972,893$38,412,227$32,493,548-$5,918,679-15.41%
Two Sigma Investments, Lp0.03%1,715,349$33,397,845$28,251,798-$5,146,047-15.41%
Mpm Bioimpact Llc1.91%1,606,967$31,287,647$26,466,746-$4,820,901-15.41%
Jpmorgan Chase & Co0.00%1,386,422$27,603,662$22,834,370-$4,769,292-17.28%
Vivo Capital, Llc2.49%1,400,000$27,258,000$23,058,000-$4,200,000-15.41%
Point72 Asset Management, L.P.0.03%1,158,732$22,560,512$19,084,316-$3,476,196-15.41%
Blackrock, Inc.0.00%1,094,791$21,315,581$18,031,208-$3,284,373-15.41%
Balyasny Asset Management L.P.0.03%912,715$17,770,561$15,032,416-$2,738,145-15.41%
Great Point Partners Llc3.93%855,813$16,662,679$14,095,240-$2,567,439-15.41%
Jane Street Group, Llc0.01%853,386$16,615,426$14,055,267-$2,560,159-15.41%
Candriam S.C.A.0.07%769,766$14,972,924$12,678,046-$2,294,878-15.33%
Bank Of America Corp0.00%751,897$14,639,435$12,383,744-$2,255,691-15.41%
Arrowstreet Capital, Limited Partnership0.01%750,777$14,617,628$12,365,297-$2,252,331-15.41%
Trails Edge Capital Partners, Lp2.32%750,000$14,602,500$12,352,500-$2,250,000-15.41%
Renaissance Technologies LLCJim Simons0.02%643,268$12,524,428$10,594,624-$1,929,804-15.41%
Millennium Management Llc0.01%636,187$12,386,561$10,478,000-$1,908,561-15.41%
Morgan Stanley0.00%563,602$10,973,331$9,282,525-$1,690,806-15.41%
Marshall Wace, Llp0.01%550,351$10,715,334$9,064,281-$1,651,053-15.41%
Qube Research & Technologies Ltd0.01%496,242$9,661,832$8,173,106-$1,488,726-15.41%
Algert Global Llc0.09%386,960$7,534,111$6,373,231-$1,160,880-15.41%
Rhenman & Partners Asset Management Ab0.71%384,800$7,492,056$6,337,656-$1,154,400-15.41%
Trexquant Investment Lp0.05%377,946$7,358,609$6,224,771-$1,133,838-15.41%
Capricorn Fund Managers Ltd0.58%374,866$7,294,892$6,174,043-$1,120,849-15.36%
Aqr Capital Management Llc0.00%358,884$6,987,471$5,910,819-$1,076,652-15.41%
Bnp Paribas Financial Markets0.00%341,537$6,649,725$5,625,114-$1,024,611-15.41%
Jump Financial, Llc0.06%336,243$6,546,652$5,537,922-$1,008,730-15.41%
Ubs Group Ag0.00%328,522$6,396,323$5,410,757-$985,566-15.41%
Granahan Investment Management, Llc0.22%313,884$6,111,321$5,169,669-$941,652-15.41%
Boxer Capital Management, Llc0.40%275,000$5,354,250$4,529,250-$825,000-15.41%
Susquehanna Portfolio Strategies, Llc0.08%253,974$4,944,874$4,182,952-$761,922-15.41%
Burkehill Global Management, Lp0.18%250,000$4,867,500$4,117,500-$750,000-15.41%
Holocene Advisors, Lp0.01%250,000$4,867,500$4,117,500-$750,000-15.41%
Susquehanna International Group, Llp0.00%247,742$4,823,537$4,080,311-$743,226-15.41%
Walleye Capital Llc0.02%246,869$4,806,539$4,065,932-$740,607-15.41%
J. Goldman & Co Lp0.15%215,945$4,204,449$3,556,614-$647,835-15.41%
Y-Intercept (Hong Kong) Ltd0.08%215,849$4,202,580$3,555,033-$647,547-15.41%
Acuta Capital Partners, Llc2.93%215,652$4,198,744$3,551,788-$646,956-15.41%
Verition Fund Management Llc0.03%207,102$4,032,276$3,410,970-$621,306-15.41%
Highvista Strategies Llc0.83%187,946$3,659,308$3,095,471-$563,837-15.41%
Rice Hall James & Associates, Llc0.17%183,801$3,578,605$3,027,202-$551,403-15.41%
Congress Asset Management Co0.02%180,448$3,513,323$2,971,979-$541,344-15.41%
Kalehua Capital Management Llc2.45%175,734$3,421,541$2,894,339-$527,202-15.41%
Voleon Capital Management Lp0.06%173,909$3,386,008$2,864,281-$521,727-15.41%

Frequently asked questions about MLTX

  • Who owns the most MLTX stock?

    The largest holders of MLTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MOONLAKE IMMUNOTHERAPEUTICS (MLTX).

  • Is MLTX widely held by superinvestors?

    Many widely followed stocks like MLTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly MLTX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.